A new analysis of early studies suggests that tele-robot-assisted prostatectomy, where a surgeon operates a robot from a distance, is technically feasible. In the 80 patients studied, the procedure was completed successfully in every case, with no severe complications reported. However, this is preliminary evidence from small case series, and the findings are not definitive proof of safety or effectiveness.
The analysis, which combined results from several small studies, found that the average operative time was about 190 minutes, estimated blood loss was about 72 mL, and the average hospital stay was about 5 days. The overall complication rate was 19.4%, but all complications were mild (Grade I on the Clavien-Dindo scale). The network latency, or delay in the remote connection, averaged around 160 milliseconds, which is within acceptable limits for surgery.
While these results are encouraging, the evidence base is limited. The studies were small, had short-term follow-up, and were not randomized trials. This means that the findings should be interpreted with caution. The analysis also noted that remote prostatectomy should only be performed in high-volume centers with established robotic surgery programs, robust network infrastructure, and well-defined emergency protocols.
For patients considering prostate cancer surgery, this research is not yet practice-changing. It suggests that remote surgery is possible, but more research is needed to confirm its safety and benefits compared to standard approaches. As always, patients should discuss their treatment options with their healthcare provider.